{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:56:25Z","timestamp":1789685785832,"version":"4.0.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neuroendocrine tumors (NETs) are heterogeneous group of tumors arising from enterochromaffin cells. Neuroendocrine tumors are most commonly found in bowel and pancreatic tissue. Because of paucity of enterochromaffin cells in biliary tract, NETs of bile duct are very rare. Most of the neoplasms in the extrahepatic bile duct are adenocarcinomas; only 0.2% to 0.3% of NETs arise from the bile duct. Cases reported in the literature of biliary carcinoid are diagnosed postoperatively on histopathologic evaluation. We hereby demonstrate a rare presentation of CBD NET identified preoperatively on somatostatin receptor but not on glucose transporter imaging, confirmed by histopathology and immunohistochemistry to be grade 2 NET (Ki-67, 20%).<\/jats:p>","DOI":"10.1097\/rlu.0000000000004342","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:08Z","timestamp":1660348808000},"page":"e715-e717","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Rare Case of Neuroendocrine Tumor of Common Bile Duct Identified With Somatostatin Receptor But Not With Glucose Transporter Imaging"],"prefix":"10.1097","volume":"47","author":[{"given":"Ashish","family":"Mohite","sequence":"first","affiliation":[{"name":"Nuclear Medicine and Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Shukla","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"M V","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachariah","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Pathology, Mahamana Pandit Madanmohan Malaviya Cancer Centre, Varanasi, Uttar Pradesh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"Pathology, Mahamana Pandit Madanmohan Malaviya Cancer Centre, Varanasi, Uttar Pradesh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12664-012-0197-x","article-title":"Neuroendocrine tumor of common hepatic duct","volume":"31","year":"2012","journal-title":"Indian J Gastroenterol"},{"key":"bib2-20250621","first-page":"813","article-title":"An analysis of 8305 cases of carcinoid tumors","volume":"79","year":"1997","journal-title":"Cancer"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","year":"2005","journal-title":"Gastroenterology"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12253-014-9808-4","article-title":"Neuroendocrine tumors of extrahepatic biliary tract","volume":"20","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"18048","DOI":"10.3748\/wjg.v20.i47.18048","article-title":"Primary large cell neuroendocrine carcinoma in the common bile duct: first Asian case report","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1007\/s00259-014-2805-8","article-title":"Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT","volume":"41","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00259-011-1787-z","article-title":"Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders","volume":"38","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2021.01.008","article-title":"Consensus on molecular imaging and theranostics in neuroendocrine neoplasms","volume":"146","year":"2021","journal-title":"Eur J Cancer"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:03:35Z","timestamp":1750536215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004342","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}